Publications

5808 Results

A phase II evaluation of esorubicin in ovarian cancer. A Southwest Oncology Group study.

Authors
DS Alberts;NM Liddil;D Stock-Novack;RV O'Toole;TM Abbott;SE Salmon
Journal / Conference
AJCO 15(2):146-149
Year
1992
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8402

A phase II randomized study comparing sequential and combined intra-arterial cisplatin and radiation therapy in primary brain tumors. A Southwest Oncology Group study.

Authors
JE Mortimer;J Crowley;H Eyre;P Weiden;WJ Stuckey
Journal / Conference
Cancer 69(5):1220-1223
Year
1992
Research Committee(s)
Brain
Study Number(s)
SWOG-8510

Phase II study of platinum and mitoxantrone in metastatic prostate cancer: A Southwest Oncology Group study.

Authors
CK Osborne;BA Blumenstein;ED Crawford;GR Weiss;Rm Bukowski;NR Larrimer
Journal / Conference
EJC 28:477-478
Year
1992
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8517

Analysis of treatment failure in acute non-lymphocytic leukemia patients over fifty years of age. A Southwest Oncology Group study.

Authors
DH Ryan;KJ Kopecky;D Head;MR Grever;SM Shlaer;DA Lipschitz;HE Hynes;RH Vial;RW Veith;CH Gumbart
Journal / Conference
AJCO 15(1):69-75
Year
1992
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8522

N-ras mutations in acute myelogenous leukemia: A review of the current literature and an update of the Southwest Oncology Group experience.

Authors
JP Radich;KJ Kopecky;F Appelbaum;CL Willman;SJ Collins
Journal / Conference
Leukemia and Lymphoma 6:325-334
Year
1992
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-8750

Phase II evaluation of didemnin B in advanced adenocarcinoma of the kidney: A Southwest Oncology Group study.

Authors
SA Taylor;P Goodman;ED Crawford;WJ Stuckey;RL Stephens;ER Gaynor
Journal / Conference
IND 10:55-56
Year
1992
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8728

A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma: A Southwest Oncology Group study.

Authors
BL Zidar;B Metch;SP Balcerzak;HI Pierce;L Militello;MD Keppen;JL Berenberg
Journal / Conference
Cancer 70(10):2547-2551
Year
1992
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8731

A Southwest Oncology Group phase I study of sequential combination of recombinant interferon-y and recombinant interleukin-2 in patients with cancer.

Authors
CW Taylor;EM Chase;JA Neidhart;JJ Rinehart;RP Whitehead;RC Gonzalez;PA Bunn;EM Hersh
Journal / Conference
Journal of Immunotherapy 3:176-183
Year
1992
Research Committee(s)
Developmental Biologics
Study Number(s)
SWOG-8801

Melphalan GM-CSF: A phase I study.

Authors
E Poplin;H Smith;B Behrens;B Redman;L Flaherty;J Neidhart;D Alberts
Journal / Conference
Gyn Onc 44:66-70
Year
1992
Research Committee(s)
Developmental Biologics
Study Number(s)
SWOG-8825

Prognostic significance of S-Phase fraction in good risk node-negative breast cancer patients.

Authors
MC Mathieu;MA Owens;LG Dressler;LE Eudey;DC Tormey;CK Osborne;KW Gilchrist;EG Mansour;MD Abeloff;WL McGuire
Journal / Conference
JCO 10(3):428-432
Year
1992
Research Committee(s)
Breast
Study Number(s)
SWOG-8294 (INT-0011) (EST-1180)